Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, SBS

Revolutionize Your Optometry Practice with mConsent's Paperless Office Solutions


In an age where 85% of patients expect digital engagement from their healthcare providers, mConsent emerges as the revolutionary patient engagement solution for optometry practices have been waiting for. Launching its suite of paperless and efficiency-driven tools, mConsent is set to transform the way optometrists connect with patients, streamline operations, and pave the way for unparalleled patient care and satisfaction.

PLANO, Texas, March 19, 2024 /PRNewswire/ -- mConsent, a leader in digital practice management solutions, is thrilled to announce the expansion of its services to Optometry practices. With over 5 million satisfied patients, mConsent introduces a suite of digital tools, including paperless patient intake and streamlined billing solutions, designed specifically for the modern Optometrist.

Empowering Practices with Digital Precision:

Imagine a world where patient check-ins flow seamlessly, appointments are booked in a blink, and bill payments are a breeze. This is the world mConsent brings to life for optometry practices. Our platform is a testament to how innovative solutions can transform the traditional burdens of administrative tasks into a streamlined, efficient process that captivates both staff and patients alike.

A Testament to Unparalleled Service

"mConsent makes the intake process much easier and faster at our optometry," shares Dr. Annette Hanian, practice owner at Northsight Vision Care, a leading optometrist in Scottsdale, AZ. Dr. Hanian's experience reflects the transformative impact mConsent has on practices, streamlining operations to allow more time for what truly matters - patient care.

Why mConsent Stands Above the Rest:

mConsent's comprehensive platform redefines efficiency in optometry practice management, integrating:

Samad Syed, CEO of mConsent, states, "Our mission is to empower Optometry practices to excel in today's digital era. mConsent's suite of digital patient intake, scheduling, billing, and communication tools not only boosts operational efficiency but also significantly enhances patient satisfaction. We're dedicated to shifting the focus back to what matters most?providing exceptional patient care."

About mConsent:

mConsent is your go-to patient engagement platform that streamlines healthcare practice operations, increasing office productivity, and enhancing patient satisfaction.

After implementing mConsent, participating optometry practices reported a remarkable 40% reduction in patient wait times, saved approximately $65K annually on administrative costs, reduced documentation time by 35%, and dramatically improved patient satisfaction scores.

Ready to elevate your practice with our optometry practice management software? Visit us at https://optometry.mconsent.net/ and begin your journey to a more productive and efficient practice today.

Contact Us:

Zach Lopez
Email: [email protected] 
Company: SRS Web Solutions, Inc. (mConsent)
Phone: 877-203-6767

SOURCE mConsent


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: